Back
Exxon Mobil Vs. Blueprint Medicines Industry Stock Comparison
Sell
45
XOM
Exxon Mobil
Last Price:
$109.72
Seasonality Move:
2.77%
Sell
40
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Sell
45
Exxon Mobil (XOM)
is a Sell
Is Exxon Mobil a Buy, Sell or Hold?
-
The current Exxon Mobil [XOM] share price is $109.72. The Score for XOM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
XOM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XOM Stock Price Chart
What is Exxon Mobil's stock price today?
-
The Exxon Mobil share price today is $109.72The current trend is relatively stagnant and XOM is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $102.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
XOM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.41 | Sell |
Relative Strength Index (14 RSI): | 50.29 | Buy |
Chaikin Money Flow: | 10706751 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.02 - 110.88) | Buy |
Bollinger Bands (100): | (110.35 - 120.85) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 63.82 | Buy |
Chaikin Money Flow: | -913925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.06 - 96.6) | Buy |
Bollinger Bands (100): | (86.99 - 95.95) | Buy |
XOM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 108.02 | Buy |
20-day SMA: | 107.41 | Buy |
50-day SMA: | 113.74 | Sell |
200-day SMA: | 115.94 | Sell |
8-day EMA: | 108.17 | Buy |
20-day EMA: | 108.79 | Buy |
50-day EMA: | 111.99 | Sell |
200-day EMA: | 113.85 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.93 | Buy |
20-day SMA: | 91.76 | Buy |
50-day SMA: | 93.83 | Buy |
200-day SMA: | 96.87 | Buy |
8-day EMA: | 94.89 | Buy |
20-day EMA: | 92.92 | Buy |
50-day EMA: | 92.72 | Buy |
200-day EMA: | 91.71 | Buy |
Exxon Mobil Earnings Growth & XOM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $1.24 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
Exxon Mobil Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |